Krystal Biotech, Inc. (KRYS)
239.64
+5.00
(+2.13%)
USD |
NASDAQ |
Dec 10, 16:00
240.50
+0.86
(+0.36%)
After-Hours: 18:08
Krystal Biotech Profit Margin (Quarterly): 81.15% for Sept. 30, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Alnylam Pharmaceuticals, Inc. | 20.10% |
| Vanda Pharmaceuticals, Inc. | -40.15% |
| ADMA Biologics, Inc. | 27.14% |
| Aldeyra Therapeutics, Inc. | -- |
| ACADIA Pharmaceuticals, Inc. | 25.76% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 19.91% |
| Return on Assets | 18.11% |
| Return on Invested Capital | 19.74% |
| Gross Profit Margin (Quarterly) | 94.21% |
| Operating Margin (Quarterly) | 42.30% |
| Return on Net Operating Assets | 66.39% |